M03 Using CGM For Day-To-Day Insulin-Dosing Decisions

Program: Meet-the-Professor Sessions
Clinical Session
Friday, April 1, 2016: 2:15 PM-3:00 PM
Room 156 (BCEC)
Friday, April 1, 2016: 3:30 PM-4:15 PM
Room 156 (BCEC)
Speaker:
Steven Victor Edelman, MD, University of California-San Diego/VA Medical Center, Del Mar, CA

Nothing to Disclose: SVE

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire